Insider · CIK 0001789490

Fletcher Aaron G.L.

Reports to the SEC for 8 companies · FORT WORTH, TX

sec.gov

Transactions

Companies

Filings

CIK

0001789490

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	CGTXCOGNITION THERAPEUTICS INCA Award	Director, 10% Owner	AAward	+25K sh	—	—	81,229
2026-05-21	ACTUACTUATE THERAPEUTICS, INC. · Stock OptionsA Award	Director, 10% Owner	AAward	+15K sh	—	—	15,000
2025-09-19	CGTXCOGNITION THERAPEUTICS INCM Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+7,729 sh	$0.84	+$6,492.36	56,229
2025-09-19	CGTXCOGNITION THERAPEUTICS INC · Stock Option (right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−7,729 sh	—	—	0
2025-06-27	ACTUACTUATE THERAPEUTICS, INC. · Warrant (Right to Buy)P Purchase	Director, 10% Owner	PPurchase	+71.4K sh	—	—	71,428
2025-06-27	ACTUACTUATE THERAPEUTICS, INC.P Purchase	Director, 10% Owner	PPurchase	+71.4K sh	$7.00	+$500K	196,428
2025-06-18	CGTXCOGNITION THERAPEUTICS INCA Award	Director, 10% Owner	AAward	+34K sh	—	—	48,500
2025-06-13	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−12.3K sh	$3.09	−$38.1K	323,335
2025-06-13	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−1,903 sh	$3.09	−$5,880.27	49,957
2025-06-13	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−4,354 sh	$3.09	−$13.5K	114,272
2025-06-13	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−14.2K sh	$3.09	−$43.9K	373,178
2025-06-13	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−7,206 sh	$3.09	−$22.3K	189,117
2025-06-12	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−10.9K sh	$3.38	−$36.9K	196,323
2025-06-12	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−21.6K sh	$3.38	−$72.9K	387,396
2025-06-12	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−18.7K sh	$3.38	−$63.1K	335,654
2025-06-12	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−2,886 sh	$3.38	−$9,754.68	51,860
2025-06-12	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−6,601 sh	$3.38	−$22.3K	118,626
2025-06-11	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−293 sh	$3.40	−$996.2	354,332
2025-06-11	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−171 sh	$3.40	−$581.4	207,248
2025-06-11	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−338 sh	$3.40	−$1,149.2	408,953
2025-06-11	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−103 sh	$3.40	−$350.2	125,227
2025-06-11	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−45 sh	$3.40	−$153	54,746
2025-06-10	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−2 sh	$3.40	−$6.8	125,330
2025-06-10	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−5 sh	$3.40	−$17	409,291
2025-06-10	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−5 sh	$3.40	−$17	354,625
2025-06-10	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−3 sh	$3.40	−$10.2	207,419
2025-06-10	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−1 sh	$3.40	−$3.4	54,791
2025-05-29	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−961 sh	$3.03	−$2,911.83	54,792
2025-05-29	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−2,199 sh	$3.03	−$6,662.97	125,332
2025-05-29	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−6,221 sh	$3.03	−$18.8K	354,630
2025-05-29	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−3,639 sh	$3.03	−$11K	207,422
2025-05-29	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−7,180 sh	$3.03	−$21.8K	409,296
2025-05-28	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−1,632 sh	$2.87	−$4,683.84	127,531
2025-05-28	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−5,332 sh	$2.87	−$15.3K	416,476
2025-05-28	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−4,620 sh	$2.87	−$13.3K	360,851
2025-05-28	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−2,702 sh	$2.87	−$7,754.74	211,061
2025-05-28	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−714 sh	$2.87	−$2,049.18	55,753
2025-05-27	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−2,290 sh	$3.05	−$6,984.5	129,163
2025-05-27	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−7,478 sh	$3.05	−$22.8K	421,808
2025-05-27	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−6,479 sh	$3.05	−$19.8K	365,471
2025-05-27	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−3,790 sh	$3.05	−$11.6K	213,763
2025-05-27	LTRNLantern Pharma Inc.S Sale	10% Owner	SSale	−1,000 sh	$3.05	−$3,050	56,467
2025-05-22	ACTUACTUATE THERAPEUTICS, INC. · Stock OptionsA Award	Director, 10% Owner	AAward	+15K sh	—	—	15,000
2025-05-02	INABIN8BIO, INC. · Series B WarrantJ Other	10% Owner	JOther	−574K sh	—	—	0
2025-05-02	INABIN8BIO, INC. · Pre-Funded WarrantsP Purchase	10% Owner	PPurchase	+1.15M sh	—	—	2,431,763
2025-05-02	INABIN8BIO, INC. · Series A WarrantJ Other	10% Owner	JOther	−574K sh	—	—	0
2024-10-04	INABIN8BIO, INC. · Series A WarrantA Award	10% Owner	AAward	+574K sh	—	—	574,241
2024-10-04	INABIN8BIO, INC. · Series C WarrantP Purchase	10% Owner	PPurchase	+709K sh	—	—	709,040
2024-10-04	INABIN8BIO, INC. · Pre-Funded WarrantsP Purchase	10% Owner	PPurchase	+709K sh	—	—	1,283,281
2024-10-04	INABIN8BIO, INC. · Series A WarrantD Disposition to Issuer	10% Owner	DDisposition to Issuer	+574K sh	—	—	0

Recent filings

Accepted (ET)
Jun 224
BIOS Fund II QP, LP0001789490-26-000002
SEC(opens sec.gov)
May 224
Fletcher Aaron G.L.0001683168-26-004241
SEC(opens sec.gov)
Sep 234
Fletcher Aaron G.L.0001104659-25-092671
SEC(opens sec.gov)
Jun 304
BIOS Fund III, LP0001104659-25-063991
SEC(opens sec.gov)
Jun 204
BIOS Fund II QP, LP0001104659-25-061241
SEC(opens sec.gov)
Jun 134
BIOS Fund I, LP0001104659-25-059106
SEC(opens sec.gov)
Jun 134
BIOS Fund I, LP0001104659-25-059528
SEC(opens sec.gov)

Companies

Address

C/O BIOS EQUITY PARTNERS 1751 RIVER RUN, SUITE 400

FORT WORTH, TX, 76107